These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 23444404)
1. Murine dendritic cell rapamycin-resistant and rictor-independent mTOR controls IL-10, B7-H1, and regulatory T-cell induction. Rosborough BR; Raïch-Regué D; Matta BM; Lee K; Gan B; DePinho RA; Hackstein H; Boothby M; Turnquist HR; Thomson AW Blood; 2013 May; 121(18):3619-30. PubMed ID: 23444404 [TBL] [Abstract][Full Text] [Related]
2. mTORC2 Deficiency in Myeloid Dendritic Cells Enhances Their Allogeneic Th1 and Th17 Stimulatory Ability after TLR4 Ligation In Vitro and In Vivo. Raïch-Regué D; Rosborough BR; Watson AR; McGeachy MJ; Turnquist HR; Thomson AW J Immunol; 2015 May; 194(10):4767-76. PubMed ID: 25840913 [TBL] [Abstract][Full Text] [Related]
3. Rapamycin-treated human endothelial cells preferentially activate allogeneic regulatory T cells. Wang C; Yi T; Qin L; Maldonado RA; von Andrian UH; Kulkarni S; Tellides G; Pober JS J Clin Invest; 2013 Apr; 123(4):1677-93. PubMed ID: 23478407 [TBL] [Abstract][Full Text] [Related]
4. Involvement of mTORC1 and mTORC2 in regulation of glioblastoma multiforme growth and motility. Gulati N; Karsy M; Albert L; Murali R; Jhanwar-Uniyal M Int J Oncol; 2009 Oct; 35(4):731-40. PubMed ID: 19724909 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-15b/16 Enhances the Induction of Regulatory T Cells by Regulating the Expression of Rictor and mTOR. Singh Y; Garden OA; Lang F; Cobb BS J Immunol; 2015 Dec; 195(12):5667-77. PubMed ID: 26538392 [TBL] [Abstract][Full Text] [Related]
6. Modulatory effect of rapamycin and tacrolimus on monocyte-derived dendritic cells phenotype and function. Dahlqvist G; Renaud S; Barjon C; Lefebvre A; Aoudjehane L; Horsmans Y; Delhem N; Conti F Immunobiology; 2021 Jan; 226(1):152031. PubMed ID: 33278711 [TBL] [Abstract][Full Text] [Related]
8. mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1). García-Martínez JM; Alessi DR Biochem J; 2008 Dec; 416(3):375-85. PubMed ID: 18925875 [TBL] [Abstract][Full Text] [Related]
9. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells. Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562 [TBL] [Abstract][Full Text] [Related]
10. Requirement of B7-H1 in mesenchymal stem cells for immune tolerance to cardiac allografts in combination therapy with rapamycin. Wang H; Qi F; Dai X; Tian W; Liu T; Han H; Zhang B; Li H; Zhang Z; Du C Transpl Immunol; 2014 Aug; 31(2):65-74. PubMed ID: 24978830 [TBL] [Abstract][Full Text] [Related]
11. Hypoxia Increases IGFBP-1 Phosphorylation Mediated by mTOR Inhibition. Damerill I; Biggar KK; Abu Shehab M; Li SS; Jansson T; Gupta MB Mol Endocrinol; 2016 Feb; 30(2):201-16. PubMed ID: 26714229 [TBL] [Abstract][Full Text] [Related]
12. Targeting of mTORC2 may have advantages over selective targeting of mTORC1 in the treatment of malignant pheochromocytoma. Zhang X; Wang X; Xu T; Zhong S; Shen Z Tumour Biol; 2015 Jul; 36(7):5273-81. PubMed ID: 25666752 [TBL] [Abstract][Full Text] [Related]
13. Identification of rictor as a novel substrate of Polo-like kinase 1. Shao T; Liu X Cell Cycle; 2015; 14(5):755-60. PubMed ID: 25714006 [TBL] [Abstract][Full Text] [Related]
14. mTORC1 couples immune signals and metabolic programming to establish T(reg)-cell function. Zeng H; Yang K; Cloer C; Neale G; Vogel P; Chi H Nature; 2013 Jul; 499(7459):485-90. PubMed ID: 23812589 [TBL] [Abstract][Full Text] [Related]
15. T Cells Encountering Myeloid Cells Programmed for Amino Acid-dependent Immunosuppression Use Rictor/mTORC2 Protein for Proliferative Checkpoint Decisions. Van de Velde LA; Subramanian C; Smith AM; Barron L; Qualls JE; Neale G; Alfonso-Pecchio A; Jackowski S; Rock CO; Wynn TA; Murray PJ J Biol Chem; 2017 Jan; 292(1):15-30. PubMed ID: 27903651 [TBL] [Abstract][Full Text] [Related]
16. Mechanistic target of rapamycin complex 2 protects the heart from ischemic damage. Völkers M; Konstandin MH; Doroudgar S; Toko H; Quijada P; Din S; Joyo A; Ornelas L; Samse K; Thuerauf DJ; Gude N; Glembotski CC; Sussman MA Circulation; 2013 Nov; 128(19):2132-44. PubMed ID: 24008870 [TBL] [Abstract][Full Text] [Related]